Achillion Pharmaceuticals Inc (NASDAQ:ACHN)

9.23
Delayed Data
As of May 22
 +0.12 / +1.32%
Today’s Change
2.65
Today|||52-Week Range
16.87
-24.65%
Year-to-Date

Today’s Trading

Previous close9.11
Today’s open9.13
Day’s range9.05 - 9.27
Volume4,080,971
Average volume (3 months)3,622,269
Market cap$1.1B
Dividend yield--
Data as of 3:59pm ET, 05/22/2015

Growth & Valuation

Earnings growth (last year)-11.11%
Earnings growth (this year)+7.31%
Earnings growth (next 5 years)+5.23%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book6.66

Competitors

 Today’s
change
Today’s
% change
SRPTSarepta Therapeutics...+1.96+8.08%
PDLIPDL BioPharma Inc+0.02+0.30%
FOLDAmicus Therapeutics ...0.000.00%
PRTAProthena Corporation...+0.53+1.58%
Data as of 3:59pm ET, 05/22/2015

Financials

Next reporting dateAugust 5, 2015
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$0.00
Annual profit (last year)-$69.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Milind S. Deshpande
CFO, Secretary, EVP &
Investor Relations Contact
Mary Kay Fenton
Corporate headquarters
New Haven, Connecticut

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers